GLP-1 receptor agonists have changed the landscape of obesity treatment, offering levels of weight loss once thought unattainable without surgery. But what happens after the weight is lost? And can we really talk about success without talking about maintenance?
While much of the public discourse fixates on dramatic weight loss numbers, the harder question is what comes next. Can lifestyle interventions alone sustain weight loss after GLP-1 cessation? How do metabolic adaptations and behavioral relapse factor in? And what does the data actually show about relapse rates, nutritional adequacy, and lean mass preservation when using these medications?
In this episode, Danny sits down with Tara Schmidt, dietitian at the Mayo Clinic, to examine the intersection of pharmacology and behavior in long-term weight management.
Tara Schmidt is a registered dietitian and an instructor of nutrition at Mayo Clinic. As the lead dietitian for the Mayo Clinic Diet, she provides guidance rooted in evidence-based principles. She hosts the Mayo Clinic On Nutrition podcast and co-authored The Mayo Clinic Diet: Weight Loss Medications Edition.
Timestamps
- [05:17] Understanding weight loss maintenance
- [08:44] Defining success in weight loss maintenance
- [11:54] Predictors of maintenance: self-monitoring and behavioral strategies
- [23:37] Pharmacological interventions: GLP-1 receptor agonists
- [31:06] Dietary considerations for those taking GLP-1 RAs
- [37:07] Addressing misconceptions about weight loss drugs
- [42:48] Final thoughts and takeaways
- [48:49] Key ideas (Premium-only)
Links/Resources
